1985
DOI: 10.1016/0007-0971(85)90027-0
|View full text |Cite
|
Sign up to set email alerts
|

An evaluation of the foot pump as a driving source for nebulizer solutions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1986
1986
2014
2014

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…A key limitation of jet nebulizers in developing contexts is that they require significant amounts of electric power, on the order of 100 W. Regions where electricity is non-existent or unreliable experience increased incidence of respiratory diseases, for example, those caused by indoor air pollution [20,21]. Ultrasonic and vibrating mesh nebulizers require less power than jet nebulizers, but their higher cost and need for battery recharging still exists.…”
Section: Introductionmentioning
confidence: 99%
“…A key limitation of jet nebulizers in developing contexts is that they require significant amounts of electric power, on the order of 100 W. Regions where electricity is non-existent or unreliable experience increased incidence of respiratory diseases, for example, those caused by indoor air pollution [20,21]. Ultrasonic and vibrating mesh nebulizers require less power than jet nebulizers, but their higher cost and need for battery recharging still exists.…”
Section: Introductionmentioning
confidence: 99%
“… 4 This medical foot pump compressor ( www.asthmarelief.co.uk ) passed a WHO schedule as it was being considered for use in a nebulised measles vaccination campaign trial that was being proposed by Albert Sabin the oral polio pioneer. It passed hospital evaluation in 1985 5 and by then was in widespread use by general medical practitioners and patients. Its United Kingdom decline was heralded by changes in asthma care, which included the use of inhaled steroids, long-acting inhaled sympathomimetics and especially spacer devices.…”
mentioning
confidence: 99%